Security record · archived quarter
ZYME
Zymeworks Inc. · Healthcare · Biotechnology
10Tracked holders
—Δ holders
2.50MShares held
$21.29MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | -2 | 24.79M | $647.06M | +6 | −8 |
| Q1 2026 | 94 | +3 | 24.89M | $623.10M | +9 | −6 |
| Q4 2025 | 90 | -1 | 25.71M | $677.12M | — | −1 |
| Q3 2025 | 19 | +2 | 15.73M | $268.60M | +2 | −1 |
| Q2 2025 | 15 | +1 | 10.33M | $129.64M | +1 | — |
| Q1 2025 | 11 | 0 | 3.31M | $39.41M | +1 | −1 |
| Q4 2024 | 11 | -2 | 3.00M | $43.95M | — | −2 |
| Q3 2024 | 12 | +2 | 2.16M | $27.11M | +2 | — |
| Q2 2024 | 10 | — | 2.50M | $21.29M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 712.95K | — | $6.07M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 712.95K | — | $6.07M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 599.38K | — | $5.10M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 599.38K | — | $5.10M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 334.78K | — | $2.85M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 334.78K | — | $2.85M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 334.78K | — | $2.85M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 334.78K | — | $2.85M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 236.78K | — | $2.02M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Norges Bank ✦ (passive) | 201.70K | — | $1.72M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 197.76K | — | $1.68M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 94.27K | — | $802,255 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 94.27K | — | $802,255 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 63.60K | — | $541,236 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 43.76K | — | $372,364 | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 17.07K | — | $146,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 209 holders, 70.12M shares, $1.75B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API